- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
- Paralegals
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
October 3, 2023Casey Matthiesen Honored with Profiles in Diversity Journal’s Native American/Indigenous Leadership Award
-
September 28, 2023Robins Kaplan Ranks in Top 10% For Pro Bono By Law360
-
September 25, 2023Jake Holdreith Admitted to American College of Trial Lawyers
-
October 4, 2023Lying, Cheating, and Stealing Seminar 2023
-
October 12, 2023Mass Torts Made Perfect
-
October 27, 2023LGBTQ Legal Services: Transgender Name Change Clinic
-
September 2023Evenstad Family Trial Aftermath: Rule 408 May Not Be Used as a Sword and Shield
-
September 2023Meet Our Keynote Speaker: Journalist and New York Times Contributor Katie Engelhart
-
September 2023Walking the Razor’s Edge: Client Capacity and the Attorney-Client Relationship
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Elmiron-Related Injuries: Maculopathy
You must read the following notice before sending an e-mail message to Robins Kaplan LLP.
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
How Can An Eye Doctor Tell If I Have Maculopathy?
During a comprehensive eye exam, an eye doctor (or, ophthalmologist) will perform a diagnostic procedure called a “dilated fundus exam.” First, the eye doctor gives the patient special eye drops that dilate the pupil of the eye. Then, the doctor uses an ophthalmoscope to view or take photographs of the “fundus” of the eye, which is the interior surface opposite the lens.
When a pupil is dilated, it opens wide, and allows an eye doctor to clearly see the back of the eye, where signs of eye disease that may lead to blindness can be identified. During this process, an eye doctor can clearly see the retina and other important parts of the eye. While viewing the retina, the doctor can identify signs of macular degeneration, such as yellow spots beneath the retina called “drusen” or dark clumps of pigment.
This video by the National Eye Institute, a division of the National Institutes of Health, shows what a doctor sees when the doctor performs a dilated fundus exam:
While it is estimated that more than 10 million Americans have a form of macular degeneration, authors of several peer-reviewed journal articles investigating a link between Elmiron use and macular degeneration have observed through dilated fundus imaging that certain Elmiron users may show a “distinctive clinical phenotype” of “a unique pigmentary maculopathy.” That is to say, those who suffer from Elmiron-related vision loss may have a unique and distinctive injury that can be attributed to Elmiron.
Before making any changes to your medication or treatment, please discuss with your healthcare providers first.
How Robins Kaplan Law Firm Can Help With Your Elmiron Lawsuit
Our nationally recognized mass tort attorneys assist clients who are seriously injured by dangerous and defective products, and we are available to evaluate your potential claim against the manufacturers of Elmiron.
Robins Kaplan’s medical and pharmaceutical attorneys have the experience to take on big drug companies. Our team of attorneys, registered nurses, paralegals, and case assistants will thoroughly investigate your case by doing the following as needed:
- Upon commencement of legal representation, one of our attorneys, legal nurses or paralegals will call you and discuss your relevant medical history and prescription drug use.
- We will order and review your medical and pharmaceutical records, and we will determine if you took a potentially harmful drug, and we will evaluate whether that drug hurt you.
- Our pharmaceutical lawyers will compare the laws of your state with the timeline of events, including, key dates in your medical timeline and dates of certain acts or omissions by the medicine manufacturer, and we will plan the best litigation strategy for your case.
- We will investigate whether the drug manufacturer complied with FDA regulations and whether the manufacturer warned you about risks and side effects associated with the drug.
Throughout the entire process, our legal team will keep you informed about your case.
Diagnosed with Maculopathy After Taking Elmiron Pentosan Medication?
Contact us for a free and confidential evaluation today. To get started, call 1.800.610.7562 or fill out our online contact form above.
1 https://www.macular.org/what-macular-degeneration.
2 Hanif AM, Jain N. Clinical Pearls for a New Condition: Pentosan polysulfate therapy, a common treatment for interstitial cystitis, has been associated with a maculopathy. Review of Ophthalmolgy. 2019 July 10.
3 Pearce WA, Chen R, Jain N. Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium. Ophthalmology. 2018 Nov;125(11):1793-1802.
RELATED PROFESSIONALS
Rayna E. Kessler
Partner
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.